Early Pituitary-Adrenal Responses and Retinopathy of Prematurity in Very Low Birth Weight Infants

Pediatric Research

Volumn 55, Issue 1, 2004, Pages 114-119

  Ng, Pak Cheung ^a   Kwok, Alvin Kwan Ho ^a   Lee, Cheuk Hon ^a   Tam, Barbara Sau Man ^a   Lam, Christopher Wai Kei ^a   Ma, Kwok Chiu ^a   Chan, Iris Hiu Shuen ^a   Wong, Eric ^a   Lam, Dennis Shun Chiu ^a   Fok, Tai Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; CORTICOTROPIN BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD; PRIORITY JOURNAL; PROVOCATION TEST; RETINA; RETROLENTAL FIBROPLASIA; RISK FACTOR; VERY LOW BIRTH WEIGHT;

ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LONGITUDINAL STUDIES; MALE; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETINOPATHY OF PREMATURITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0345731286     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000100464.09953.C9     Document Type: Article

References (51)

1. Crowley P 2002 Prophylactic corticosteroids for preterm birth (Cochrane Review). In: The Cochrane Library, Issue 4. Update Software. Oxford, UK
2. Halliday HL, Ehrenkranz RA 2003 Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford. UK
3. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT, Neonatal Ventilation Study Group 2002 High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 347:643-652
4. The STOP-ROP Multicenter Study Group 2000 Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105:295-310
5. Phelps DL 2001 Retinopathy of prematurity: clinical trials. Neoreviews 2:e167-e172
6. Bancalari E, Flynn J, Goldberg RN, Bawol R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E 1987 Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 79:663-669
7. Gaynon MW, Stevenson DK, Sunshine P, Fleischer BE, Landers MD 1997 Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol 17:434-438
8. Saugstad OD 1990 Oxygen toxicity in the neonatal period. Acta Paediatr Scand 79:881-892
9. Hussain N, Clive J, Bhandari V 1999 Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 104:e26
10. Ng PC, Lee CH, Lam CWK, Ma KC, Fok TF, Chan IHS, Wong E 2004 Transient adrenocortical insufficiency of prematurity (TAP) and systemic hypotension in very low birth weight infants. Arch Dis Child (in press)
11. Watterberg KL, Gerdes JS, Cook KL 2001 Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 50:190-195
12. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL 2000 Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 105:320-324
13. Huysman MWA, Hokken-Koelega ACS, De Ridder MAJ, Sauer PJJ 2000 Adrenal function in sick very preterm infants. Pediatr Res 48:629-633
14. Helbock HJ, Insoft RM, Conte FA 1993 Glucocorticoid responsive hypotension in extremely low birth weight newborns. Pediatrics 92:715-717
15. Ng PC, Lam CWK, Fok TF, Lee CH, Ma KC, Chan IHS, Wong E 2001 Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child 84:F122-F124
16. Danis RP, Bingaman DP, Yang Y, Ladd B 1996 Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103:2099-2104
17. Ishibashi T, Miki K, Sorgenti N, Patterson R, Ryan SJ 1985 Effects of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 3:708-711
18. Lawas-Alejo PA, Slivka S, Hernandez H, Bry K, Hallman M 1999 Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits. Pediatr Res 45:313-317
19. Randhawa P, Hass M, Frank L, Massaro D 1986 Dexamethasone increases superoxide dismutase activity in serum-free rat fetal lung organ cultures. Pediatr Res 20:895-898
20. Frank L, Lewis PL, Sosenko IR 1985 Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 75:569-574
21. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G 1992 A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule I and intercellular adhesion molecules I. Proc Natl Acad Sci USA 89:9991-9995
22. Sobel DB, Philip AGS 1992 Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics 90:529-533
23. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD 1998 Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 116:601-605
24. Ng PC, Wong GWK, Lam CWK, Lee CH, Wong MY, Fok TF, Wong W, Chan DC 1997 The pituitary-adrenal responses to exogenous human corticotrophin releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab 82:797-799
25. Karlsson R, Kallio J, Irjala K, Ekblad S, Toppari J, Kero P 2000 Adrenocorticotropin and releasing-releasing hormone tests in preterm infants. J Clin Endocrinol Metab 85:4592-4595
26. The Committee for the Classification of Retinopathy of Prematurity 1984 An international classification of retinopathy of prematurity. Arch Ophthalmol 102:1130-1134
27. Ng PC, Lee CH, Lam CWK, Ma KC, Chan IHS, Wong E, Fok TF 2004 Early pituitary-adrenal response and respiratory outcomes in preterm infants. Arch Dis Child (in press)
28. Ng PC, Lam CWK, Lee CH, Ma KC, Fok TF, Chan IHS, Wong E 2002 Reference ranges and factors affecting the human corticotropin releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab 87:4621-4628
29. Brieman I, Friedman JH, Olshen RA, Stone CJ 1993 Classification and regression trees. Chapman and Hall, New York, pp 18-55
30. Fok TF, Lam K, Dolovich M, Ng PC, Wong W, Cheung KL, So KW 1999 Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome. Arch Dis Child 80:F203-F208
31. Charles JB, Ganthier R, Appiah AP 1991 Incidence and characteristics of retinopathy of prematurity in a low-income inner-city population. Ophthalmology 98:14-17
32. Ng PC, Wong GWK, Lam CWK, Lee CH, Wong MY, Fok TF, Wong W, Chan DC 1997 Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J Clin Endocrinol Metab 82:3548-3552
33. Smith LEH 2002 Pathogenesis of retinopathy of prematurity. Acta Paediatr (Suppl) 437:26-28
34. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG 1995 Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555
35. Hellstrom A, Perruzzi C, Ju M, Engström E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LEH 2001 Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA 98:5804-5808
36. Rotschild T, Nandgaonkar BN, Yu K, Higgins RD 1999 Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr Res 46:94-100
37. Haroon Parupia MF, Dhanireddy R 2001 Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 21:242-247
38. Ramanathan R, Siassi B, deLemos RA 1995 Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol 15:178-182
39. Termote J, Schali-Delfos NE, Donders AR, Cats BP 2000 Do postnatal glucocorticoids and retinopathy of prematurity relate? Am J Perinatol 17:291-298
40. Batton DG, Roberts C, Trese M, Maisels MJ 1992 Severe retinopathy of prematurity and steroid exposure. Pediatrics 90:534-536
41. Cuculich PS, DeLozier KA, Mellen BG, Shenai JP 2001 Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates. Biol Neonate 79:9-14
42. Jacobs MA, Blanco CE 1998 The incidence of retinopathy of prematurity and steroid therapy for broncho-pulmonary dysplasia. J Perinat Med 26:13-16
43. Wright K, Wright SP 1994 Lack of association of glucocorticoid therapy and retinopathy of prematurity. Arch Pediatr Adolesc Med 148:848-852
44. Halliday HL, Ehrenkranz RA, Doyle LW 2003 Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, UK
45. Halliday HL, Ehrenkranz RA, Doyle LW 2003 Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, UK
46. Vincer MJ, Allen AC 1998 Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW < 1500 grams) who are ventilator dependent at 4 weeks of age. Pediatr Res 43:201A(abstr)
47. Suske G, Oestreich K, Varnholt V, Lasch P, Kachel W 1996 Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants. Acta Paediatr 85:713-718
48. Brozanski BS, Jones JG, Gilmore CH, Balsan MJ, Vazquez RL, Israel BA, Newman B, Mimouni FB, Guthrie RD 1995 Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant. J Pediatr 126:769-776
49. Durand M, Sardesai S, McEvoy C 1995 Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomised controlled trial. Pediatrics 95:584-590
50. Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG, Dillard RG 1999 Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants. Pediatrics 104:22-27
51. Watterberg KL, Gerdes JS, Gifford KL, Lin HM 1999 Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 104:1258-1263